Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
All News
Headline News
Press Releases
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
99 100 Next >
Celldex Initiates Phase 2 Study of Barzolvolimab in Atopic Dermatitis
From Celldex Therapeutics, Inc.
Via GlobeNewswire
Tickers CLDX
reAlpha Plans to Allocate up to 25% of Excess Cash to Cryptocurrency Purchases
From reAlpha Tech Corp.
Via GlobeNewswire
Tickers AIRE
Allegro MicroSystems to Showcase Its Dynamic Sensing and Power Solutions at CES 2025
From Allegro MicroSystems, Inc.
Via GlobeNewswire
Tickers ALGM
D. Boral Capital Acted as Exclusive Placement Agent to Webuy Global Ltd (Nasdaq: WBUY) in connection with its $3.7 Million Registered Direct Offering
From D. Boral Capital
Via GlobeNewswire
Tickers WBUY
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs
From Assembly Biosciences, Inc.
Via GlobeNewswire
Tickers ASMB
Sky Quarry Inc. Issues Annual Shareholder Letter and Corporate Update
From Sky Quarry Inc
Via GlobeNewswire
Tickers SKYQ
Driivz Concludes 2024 with Significant Growth for its EV Charging & Energy Management Platform
From Driivz
Via GlobeNewswire
Tickers VNT
Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five
From Aquestive Therapeutics, Inc.
Via GlobeNewswire
Tickers AQST
authID Bolsters Security and Transparency for Philanthropy Efforts with Program Expansion at EinStrong Foundation
From authID Inc.
Via GlobeNewswire
Tickers AUID
Gaxos.ai Inc. Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From GAXOS.AI INC.
Via GlobeNewswire
Tickers GXAI
Immuneering Launches Pancreatic Cancer Advisory Board
From Immuneering Corporation
Via GlobeNewswire
Tickers IMRX
Ultragenyx Submits Biologics License Application to the U.S. FDA for UX111 AAV Gene Therapy for the Treatment of Sanfilippo Syndrome Type A (MPS IIIA)
From Ultragenyx Pharmaceutical Inc.
Via GlobeNewswire
Tickers RARE
illumin Announces TSX Acceptance of Normal Course Issuer Bid
From illumin
Via GlobeNewswire
Tickers ILLMF TSX:ILLM
Franklin Energy Acquires AESC, Unleashing a New Era of Clean Energy Leadership
From Franklin Energy
Via GlobeNewswire
Silynxcom Unveils Innovative Headset to Enhance Drone Detection for Armored Vehicle Crews
From Silynxcom Ltd.
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ARCH on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Tickers ARCH CARA NURO
FTI Consulting Survey Identifies Renewed Optimism as Healthcare & Life Sciences Sector Embarks on 2025
From FTI Consulting, Inc.
Via GlobeNewswire
Tickers FCN
XOMA Royalty Declares Quarterly Preferred Stock Dividends
From XOMA Royalty Corporation
Via GlobeNewswire
Tickers XOMA XOMAO XOMAP
FuelCell Energy Reports Fourth Quarter and Full Fiscal Year 2024 Results
From FuelCell Energy, Inc.
Via GlobeNewswire
Tickers FCEL
Xilio Therapeutics to Present Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI
From Xilio Therapeutics, Inc.
Via GlobeNewswire
Tickers XLO
SweetWater Brewing Announces 28th Anniversary Bash With STS9 Headlining an Immersive Jamtronica Experience
From Tilray Brands, Inc.
Via GlobeNewswire
Tickers TLRY TSX:TLRY
Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs
From Polyrizon Ltd.
Via GlobeNewswire
Tickers PLRZ
EnviroGold Global Announces Private Placement
From EnviroGold Global Limited
Via GlobeNewswire
Tickers CSE:NVRO ESGLF
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Tickers LFCR
Tilray Brands, Inc. to Announce Second Quarter Fiscal Year 2025 Financial Results on January 9, 2025
From Tilray Brands, Inc.
Via GlobeNewswire
Tickers TLRY TSX:TLRY
PyroGenesis Announces Debt-to-Equity Conversion of Client Receivable
From PyroGenesis Inc.
Via GlobeNewswire
Tickers PYRGF TSX-V:HPQ TSX:PYR
NewGen Engages OSL to Execute Strategic Investment in Digital Assets
From NewGenIVF Limited
Via GlobeNewswire
Tickers NIVF
Regeneron to Advance Two Factor XI Antibodies into a Broad Phase 3 Program Following Positive Phase 2 Proof-of-concept Results
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers REGN
Climb Bio to be Added to the Nasdaq Biotechnology Index
From Climb Bio, Inc.
Via GlobeNewswire
Tickers CLYM
Bio-Path Holdings Announces Preclinical Testing of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients Enhances Insulin Sensitivity
From Bio-Path Holdings, Inc.
Via GlobeNewswire
Tickers BPTH
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.